Spectral Analysis of Heart Rate Variability: Time Window Matters

by Kai Li, Kai Li, Heinz Rüdiger, Tjalf Ziemssen, Tjalf Ziemssen
Published 2019-05-01

Why Cognitive–Cognitive Dual-Task Testing Assessment Should Be Implemented in Studies on Multiple Sclerosis and in Regular Clinical Practice

by Christian Beste, Tjalf Ziemssen
Published 2020-08-01

Alemtuzumab in the long-term treatment of relapsing-remitting multiple sclerosis: an update on the clinical trial evidence and data from the real world

by Tjalf Ziemssen, Katja Thomas
Published 2017-10-01

Review: Treatment of dysautonomia in extrapyramidal disorders

by Tjalf Ziemssen, Heinz Reichmann
Published 2010-01-01

The Investigation of the Cardiovascular and Sudomotor Autonomic Nervous System—A Review

by Tjalf Ziemssen, Timo Siepmann
Published 2019-02-01

The Change of Fingolimod Patient Profiles over Time: A Descriptive Analysis of Two Non-Interventional Studies PANGAEA and PANGAEA 2.0

by Tjalf Ziemssen, Ulf Schulze-Topphoff
Published 2021-06-01

Therapy satisfaction and adherence in patients with relapsing–remitting multiple sclerosis: the THEPA-MS survey

by Rocco Haase, Jennifer S. Kullmann, Tjalf Ziemssen
Published 2016-07-01

Molecular biomarkers in multiple sclerosis

by Tjalf Ziemssen, Katja Akgün, Wolfgang Brück
Published 2019-12-01

Fatigue and Sleep in Multiple Sclerosis Patients: A Comparison of Self-Report and Performance-Based Measures

by Madlen Paucke, Simone Kern, Tjalf Ziemssen
Published 2018-01-01

Modulation of Cardiac Autonomic Function by Fingolimod Initiation and Predictors for Fingolimod Induced Bradycardia in Patients with Multiple Sclerosis

by Kai Li, Kai Li, Urszula Konofalska, Katja Akgün, Manja Reimann, Heinz Rüdiger, Rocco Haase, Tjalf Ziemssen, Tjalf Ziemssen
Published 2017-10-01

Autonomic Dysfunction in Wilson's Disease: A Comprehensive Evaluation during a 3-Year Follow Up

by Kai Li, Kai Li, Charlotte Lindauer, Rocco Haase, Heinz Rüdiger, Heinz Reichmann, Ulrike Reuner, Tjalf Ziemssen, Tjalf Ziemssen
Published 2017-10-01

Should We Use Clinical Tools to Identify Disease Progression?

by Hernan Inojosa, Undine Proschmann, Katja Akgün, Tjalf Ziemssen
Published 2021-01-01

Demands on response inhibition processes determine modulations of theta band activity in superior frontal areas and correlations with pupillometry – Implications for the norepineph...

by Gabriel Dippel, Moritz Mückschel, Tjalf Ziemssen, Christian Beste
Published 2017-08-01

Daily Practice Managing Resistant Multiple Sclerosis Spasticity With Delta-9-Tetrahydrocannabinol: Cannabidiol Oromucosal Spray: A Systematic Review of Observational Studies

by Katja Akgün, Ute Essner, Cordula Seydel, Tjalf Ziemssen
Published 2019-03-01

Data Collection in Multiple Sclerosis: The MSDS Approach

by Tjalf Ziemssen, Raimar Kern, Isabel Voigt, Rocco Haase
Published 2020-06-01

Fingolimod Leads to Immediate Immunological Changes Within 6 h After First Administration

by Tony Sehr, Katja Akgün, Rocco Haase, Tjalf Ziemssen
Published 2020-05-01

Natalizumab Pharmacokinetics and -Dynamics and Serum Neurofilament in Patients With Multiple Sclerosis

by Undine Proschmann, Hernan Inojosa, Katja Akgün, Tjalf Ziemssen
Published 2021-04-01

Approach to SARS-CoV-2 Vaccination in Patients With Multiple Sclerosis

by Christina Woopen, Katharina Schleußner, Katja Akgün, Tjalf Ziemssen
Published 2021-06-01

Gender disparities in health resource utilization in patients with relapsing–remitting multiple sclerosis: a prospective longitudinal real-world study with more than 2000 patients...

by Dirk Schriefer, Nils-Henning Ness, Rocco Haase, Tjalf Ziemssen
Published 2020-10-01

Editorial: Cognitive Disorders in Neuroimmunological Diseases

by Tjalf Ziemssen, Dawn Wendy Langdon, Pasquale Calabrese, Pasquale Calabrese
Published 2020-03-01